Primary fallopian tube carcinoma: Results of a retrospective analysis of 64 patients

Gynecologic Oncology

Volumn 115, Issue 1, 2009, Pages 97-101

  Pectasides, D ^a   Pectasides, E ^a   Papaxoinis, G ^a   Andreadis, C ^b   Papatsibas, G ^a   Fountzilas, G ^c   Pliarchopoulou, K ^a   Macheras, A ^a   Aravantinos, G ^d   Economopoulos, T ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b THEAGENIO CANCER HOSPITAL   (Greece)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^d AGII ANARGIRI CANCER HOSPITAL   (Greece)

Author keywords

Chemotherapy; Fallopian tube carcinoma; Paclitaxel; Platinum; Prognosis

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; PACLITAXEL;

ABDOMINAL HYSTERECTOMY; ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER REGISTRY; CANCER SURVIVAL; CYTOREDUCTIVE SURGERY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE BIOPSY; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SALPINGOOOPHORECTOMY; SURVIVAL TIME; UTERINE TUBE CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; DOXORUBICIN; FALLOPIAN TUBE NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PACLITAXEL; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 69249215210     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.06.025     Document Type: Article

References (38)

1. Sedlis A. Primary carcinoma of the fallopian tube. Obstet. Gynecol. Surv. 16 (1961) 209-226
2. Brown M.D., Kohorn E.I., Kapp D.S., Schwartz P.E., and Merino M. Fallopian tube carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 11 (1985) 583-590
3. Riska A., Leminen A., and Pukkala E. Sociodemographic determinants of incidence of primary fallopian tube carcinoma, Finland 1953-97. Int. J. Cancer 104 (2003) 643-645
4. Rosenblatt K.A., Weiss N.S., and Schwartz S.M. Incidence of malignant fallopian tube tumors. Gynecol. Oncol. 35 (1989) 236-239
5. Woolas R.P., Smith J.H.F., Sarharnis P., Paterson M.E.L., and Sharp F. Fallopian tube carcinoma: an under-recognized primary neoplasm. Int. J. Gynecol. Cancer 7 (1997) 284-288
6. Henderson S.R., Harper R.C., Salazar O.M., and Rudolph J.H. Primary carcinoma of the fallopian tube: difficulties of diagnosis and treatment. Gynecol. Oncol. 5 (1977) 168-179
7. Asmussen M., Kaern J., Kjoerstad K., Wright P.B., and Abeler V. Primary adenocarcinoma localized to the fallopian tubes: report on 33 cases. Gynecol. Oncol. 30 (1988) 183-186
8. Woolas R., Jacobs I., Davies A.P., et al. What is the true incidence of primary fallopian tube carcinoma?. Int. J. Gynecol. Cancer 4 (1994) 384-388
9. Wang P.H., Yuan C.C., Chao H.T., Juang C.M., and Ng H.T. Prognosis of primary fallopian tube adenocarcinoma: report of 25 patients. Eur. J. Gynaecol. Oncol. 19 (1998) 571-574
10. Boutselis J.G., and Thompson J.N. Clinical aspects of primary carcinoma of the Fallopian tube: a clinical study of 14 cases. Am. J. Obstet. Gynecol. 111 (1971) 98-101
11. Wethington S.L., Herzog T.J., Seshan V.E., et al. Improved survival for fallopian tube cancer: a comparison of clinical characteristics and outcome for primary fallopian tube and ovarian cancer. Cancer 113 (2008) 3298-3306
12. Levite R., Fishman A., Kesler A., Altaras M., and Gadoth N. Paraneoplastic cerebellar degeneration heralding fallopian tube adenocarcinoma. Int. J. Gynecol. Cancer 11 (2001) 169-171
13. Yoonessi M. Carcinoma of the fallopian tube. Obstet. Gynecol. Surv. 34 (1979) 257-270
14. Gadducci A., Landoni F., Sartori E., et al. Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study. Gynecol. Oncol. 81 (2001) 150-159
15. Erez S., Kaplan A.L., and Wall J.A. Clinical staging of carcinoma of the uterine tube. Obstet. Gynecol. 30 (1967) 547-550
16. Klein M., Rosen A.C., Lahousen M., Graf A.H., and Rainer A. Lymphadenectomy in primary carcinoma of the fallopian tube. Cancer Lett. 147 (1999) 63-66
17. Pectasides D., Barbounis V., Sintila A., Varthalitis I., Dimitriadis M., and Athanassiou A. Treatment of primary fallopian tube carcinoma with cisplatin-containing chemotherapy. Am. J. Clin. Oncol. 17 (1994) 68-71
18. Muntz H.G., Tarraza H.M., Goff B.A., et al. Combination chemotherapy in advanced adenocarcinoma of the fallopian tube. Gynecol. Oncol. 40 (1991) 268-273
19. Gemignani M.L., Hensley M.L., Cohen R., Venkatraman E., Saigo P.E., and Barakat R.R. Paclitaxel-based chemotherapy in carcinoma of the fallopian tube. Gynecol. Oncol. 80 (2001) 16-20
20. Baekelandt M., Jorunn Nesbakken A., Kristensen G.B., Trope C.G., and Abeler V.M. Carcinoma of the fallopian tube. Cancer 89 (2000) 2076-2084
21. Hu C.Y., Taymor M.L., and Hertig A.T. Primary carcinoma of the fallopian tube. Am. J. Obstet. Gynecol. 59 (1950) 58-67
22. Sedlis A. Carcinoma of the fallopian tube. Surg. Clin. North Am. 58 (1978) 121-129
23. World Health Organization. WHO handbook for reporting results of cancer treatment (WHO Offset Publication No 48) (1979), World Health Organization, Geneva, Switzerland
24. Markman M., Zaino R., Busowski J., and Barakat R. Carcinoma of the fallopian tube. In: Hoskins W.J., Perez C.A., and Young R.C. (Eds). Principles and practice of gynecologic oncology (1992), JB Lippincott Co, Philadelphia 783
25. Huber-Buchholz M.M., Buchholz N.P., and Staehelin J. Analysis of 23 cases of primary carcinoma of the fallopian tube over 50 years. J. Obstet. Gynaecol. Res. 22 (1996) 193-199
26. Rose P.G., Piver M.S., and Tsukada Y. Fallopian tube cancer. The Roswell Park experience. Cancer 66 (1990) 2661-2667
27. McMurray E.H., Jacobs A.J., Perez C.A., Camel H.M., Kao M.S., and Galakatos A. Carcinoma of the fallopian tube. Management and sites of failure. Cancer 58 (1986) 2070-2075
28. Peters III W.A., Andersen W.A., Hopkins M.P., Kumar N.B., and Morley G.W. Prognostic features of carcinoma of the fallopian tube. Obstet. Gynecol. 71 (1988) 757-762
29. Maxson W.Z., Stehman F.B., Ulbright T.M., Sutton G.P., and Ehrlich C.E. Primary carcinoma of the fallopian tube: evidence for activity of cisplatin combination therapy. Gynecol. Oncol. 26 (1987) 305-313
30. Barakat R.R., Rubin S.C., Saigo P.E., Lewis Jr. J.L., Jones W.B., and Curtin J.P. Second-look laparotomy in carcinoma of the fallopian tube. Obstet. Gynecol. 82 (1993) 748-751
31. Tresukosol D., Kudelka A.P., Edwards C.L., Fromm G.L., Mante R., and Kavanagh J.J. Primary fallopian tube adenocarcinoma: clinical complete response after salvage treatment with high-dose paclitaxel. Gynecol. Oncol. 58 (1995) 258-261
32. Ichikawa Y., Tsunoda H., Nishide K., Nishida M., and Kubo T. Metachronous carcinoma of the vulva and fallopian tube. Gynecol. Oncol. 77 (2000) 206-209
33. Wolfson A.H., Tralins K.S., Greven K.M., et al. Adenocarcinoma of the fallopian tube: results of a multi-institutional retrospective analysis of 72 patients. Int. J. Radiat. Oncol. Biol. Phys. 40 (1998) 71-76
34. Papadimitriou C.A., Peitsidis P., Bozas G., et al. Paclitaxel- and platinum-based postoperative chemotherapy for primary fallopian tube carcinoma: a single institution experience. Oncology 75 (2008) 42-48
35. Moore K.N., Moxley K.M., Fader A.N., et al. Serous fallopian tube carcinoma: a retrospective, multi-institutional case-control comparison to serous adenocarcinoma of the ovary. Gynecol. Oncol. 107 (2007) 398-403
36. Kosary C., and Trimble E.L. Treatment and survival for women with Fallopian tube carcinoma: a population-based study. Gynecol. Oncol. 86 (2002) 190-191
37. Rosen A., Klein M., Lahousen M., Graf A.H., Rainer A., and Vavra N. Primary carcinoma of the fallopian tube-a retrospective analysis of 115 patients. Austrian Cooperative Study Group for Fallopian Tube Carcinoma. Br. J. Cancer 68 (1993) 605-609
38. Eddy G.L., Copeland L.J., Gershenson D.M., Atkinson E.N., Wharton J.T., and Rutledge F.N. Fallopian tube carcinoma. Obstet. Gynecol. 64 (1984) 546-552